
    
      The primary study was to evaluate the reactogenicity, immunogenicity and protective efficacy
      of a hepatitis B vaccine in healthy neonates of HBeAg positive mothers if administered with
      or without a dose of HBIg at birth. The current study describes the long term follow up of
      these subjects between Y16 and 20 after primary vaccination.
    
  